{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362262946354224640.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.4161/cc.4.4.1564"}},{"identifier":{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.4161/cc.4.4.1564"}}],"dc:title":[{"@value":"Histone Deacetylase Inhibitors in Programmed Cell Death and Cancer Therapy"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382262946354224641","@type":"Researcher","foaf:name":[{"@value":"Paul A. Marks"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262946354224640","@type":"Researcher","foaf:name":[{"@value":"Xuejun Jiang"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"15384101"},{"@type":"EISSN","@value":"15514005"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/15384101"}],"prism:publicationName":[{"@value":"Cell Cycle"}],"dc:publisher":[{"@value":"Informa UK Limited"}],"prism:publicationDate":"2005-01-28","prism:volume":"4","prism:number":"4","prism:startingPage":"549","prism:endingPage":"551"},"reviewed":"false","url":[{"@id":"https://www.tandfonline.com/doi/pdf/10.4161/cc.4.4.1564"}],"createdAt":"2011-01-21","modifiedAt":"2018-07-02","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360848657249809792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Proteomic study identified HSP 70kDa protein 1A as a possible therapeutic target, in combination with histone deacetylase inhibitors, for lymphoid neoplasms"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848664386257792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679838339200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The HDAC Inhibitor, SAHA, Prevents Colonic Inflammation by Suppressing Pro-inflammatory Cytokines and Chemokines in DSS-induced Colitis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.4161/cc.4.4.1564"},{"@type":"CROSSREF","@value":"10.1016/j.jprot.2011.11.010_references_DOI_L45ao7Bzex05Jsp8jQJxhTYJAmE"},{"@type":"CROSSREF","@value":"10.1267/ahc.17033_references_DOI_L45ao7Bzex05Jsp8jQJxhTYJAmE"},{"@type":"CROSSREF","@value":"10.3389/fonc.2018.00198_references_DOI_L45ao7Bzex05Jsp8jQJxhTYJAmE"}]}